全文获取类型
收费全文 | 3946篇 |
免费 | 473篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 94篇 |
妇产科学 | 70篇 |
基础医学 | 609篇 |
口腔科学 | 65篇 |
临床医学 | 552篇 |
内科学 | 748篇 |
皮肤病学 | 22篇 |
神经病学 | 236篇 |
特种医学 | 97篇 |
外科学 | 598篇 |
综合类 | 88篇 |
一般理论 | 1篇 |
预防医学 | 467篇 |
眼科学 | 39篇 |
药学 | 253篇 |
肿瘤学 | 455篇 |
出版年
2021年 | 70篇 |
2020年 | 40篇 |
2019年 | 67篇 |
2018年 | 52篇 |
2017年 | 64篇 |
2016年 | 81篇 |
2015年 | 71篇 |
2014年 | 102篇 |
2013年 | 119篇 |
2012年 | 190篇 |
2011年 | 191篇 |
2010年 | 109篇 |
2009年 | 112篇 |
2008年 | 152篇 |
2007年 | 159篇 |
2006年 | 170篇 |
2005年 | 173篇 |
2004年 | 148篇 |
2003年 | 126篇 |
2002年 | 120篇 |
2001年 | 120篇 |
2000年 | 132篇 |
1999年 | 111篇 |
1998年 | 51篇 |
1997年 | 33篇 |
1996年 | 37篇 |
1995年 | 44篇 |
1994年 | 35篇 |
1992年 | 99篇 |
1991年 | 76篇 |
1990年 | 89篇 |
1989年 | 88篇 |
1988年 | 69篇 |
1987年 | 66篇 |
1986年 | 71篇 |
1985年 | 87篇 |
1984年 | 65篇 |
1983年 | 40篇 |
1982年 | 40篇 |
1979年 | 38篇 |
1978年 | 35篇 |
1977年 | 50篇 |
1976年 | 34篇 |
1974年 | 35篇 |
1973年 | 43篇 |
1972年 | 44篇 |
1971年 | 47篇 |
1970年 | 56篇 |
1969年 | 39篇 |
1968年 | 43篇 |
排序方式: 共有4426条查询结果,搜索用时 15 毫秒
51.
Arjan C.Y. Loenen David C. Noriega Carlos Ruiz Wills Jérôme Noailly Pierce D. Nunley Rainer Kirchner Keita Ito Bert van Rietbergen 《The spine journal》2021,21(3):528-537
BACKGROUND CONTEXTManual contouring of spinal rods is often required intraoperatively for proper alignment of the rods within the pedicle screw heads. Residual misalignments are frequently reduced by using dedicated reduction devices. The forces exerted by these devices, however, are uncontrolled and may lead to excessive reaction forces. As a consequence, screw pullout might be provoked and surrounding tissue may experience unfavorable biomechanical loads. The corresponding loads and induced tissue deformations are however not well identified. Additionally, whether the forced reduction alters the biomechanical behavior of the lumbar spine during physiological movements postoperatively, remains unexplored.PURPOSETo predict whether the reduction of misaligned posterior instrumentation might result in clinical complications directly after reduction and during a subsequent physiological flexion movement.STUDY DESIGNFinite element analysis.METHODSA patient-specific, total lumbar (L1–S1) spine finite element model was available from previous research. The model consists of poro-elastic intervertebral discs with Pfirrmann grade-dependent material parameters, with linear elastic bone tissue with stiffness values related to the local bone density, and with the seven major ligaments per spinal motion segment described as nonlinear materials. Titanium instrumentation was implemented in this model to simulate a L4, L5, and S1 posterolateral fusion. Next, coronal and sagittal misalignments of 6 mm each were introduced between the rod and the screw head at L4. These misalignments were computationally reduced and a physiological flexion movement of 15° was prescribed. Non-instrumented and well-aligned instrumented models were used as control groups.RESULTSPulling forces up to 1.0 kN were required to correct the induced misalignments of 6 mm. These forces affected the posture of the total lumbar spine, as motion segments were predicted to rotate up to 3 degrees and rotations propagated proximally to and even affect the L1–2 level. The facet contact pressures in the corrected misaligned models were asymmetrical suggesting non-physiological joint loading in the misaligned models. In addition, the discs and vertebrae experienced abnormally high forces as a result of the correction procedure. These effects were more pronounced after a 15° flexion movement following forced reduction.CONCLUSIONSThe results of this study indicate that the correction of misaligned posterior instrumentation can result in high forces at the screws consistent with those reported to cause screw pullout, and may cause high-tissue strains in adjacent and downstream spinal segments.CLINICAL SIGNIFICANCEProper alignment of spinal posterior instrumentation may reduce clinical complications secondary to unfavorable biomechanics. 相似文献
52.
Dayana A. Delgado Meytal Chernoff Lei Huang Lin Tong Lin Chen Farzana Jasmine Justin Shinkle Shelley A. Cole Karin Haack Jack Kent Jason Umans Lyle G. Best Heather Nelson Donald Vander Griend Joseph Graziano Muhammad G. Kibriya Ana Navas-Acien Margaret R. Karagas Habibul Ahsan Brandon L. Pierce 《Environmental health perspectives》2021,129(5)
53.
54.
Aerosol delivery in lung disease 总被引:1,自引:0,他引:1
Metered-dose inhalers are the preferred method of aerosol delivery under normal circumstances because of their convenient size, ease of use and better patient compliance. Where poor coordination exists a spacer device, breath-activated inhaler or powder inhalation should be used and if muscular weakness presents a problem a Haleraid should be tried. A clinical air pump with jet nebuliser is appropriate if these methods prove unsatisfactory; where wet aerosol has been shown to result in clearly superior effects; for very small children; and for the "brittle" asthmatic prone to sudden life-threatening attacks, especially patients living in isolated conditions. Regular checks on aerosol techniques and efficacy of therapy are important aspects of follow up and education of all patients with airflow obstruction. 相似文献
55.
Antagonist properties of d-LSD at 5-hydroxytryptamine2 receptors 总被引:1,自引:0,他引:1
The hallucinogenic agent d-lysergic acid diethylamide (d-LSD) interacts with a number of serotonin (5-hydroxytryptamine [5-HT]) receptor subtypes in the central nervous system. It has been hypothesized that hallucinosis is produced by agonist activity at 5-HT2 receptors. There exist, however, numerous data from radioligand binding, cellular, smooth muscle, and behavioral studies that suggest that d-LSD is a potent 5-HT2 antagonist. These data are reviewed in this report. In addition, d-LSD displays agonist activity at 5-HT1A and 5-HT1C receptor subtypes, as determined in biochemical studies. At the present time, agonist interactions at 5-HT1C receptors, as opposed to 5-HT2 receptors, appears to be a more likely "common mechanism of action" of hallucinogenic agents. 相似文献
56.
57.
Kapp Judith A.; Pierce Carl W.; Webb David R.; Devens Bruce; Godfrey Wayne; Fukuse Satoshi; Engleman Edgar; Lake Jeffrey P.; Magnani John I.; Maiti Pradip K.; Sehon Alec 《International immunology》1995,7(8):1319-1330
Although reliable antibodies are available that distinguishhuman suppressor T (Ts) cells from CTL and other T cells, feware available for murine Ts cells. We have developed a mAb (984D4.6.5)that, in the presence of complement, depletes alloantigen-specificTs cells but not CTL. This antibody recognizes activated TTscells but not their precursors. In these studies, flow cytometricanalysis demonstrates that 984D4.6.5 reacts with several Tscell hybridomas, cloned Th cell lines and WEHI-3 (a myelomonocytictumor cell line). Reactivity was not detected with BW5147, Thcell hybridomas, cloned Th cells, CTL lines and hybridomas,B cell lines, thymocytes, splenocytes, bone marrow cells nora variety of tumor cells. Among 984D4.6.5 positive lines, expressionis heterogeneous and the number of cells expressing high levelsof the epitope is increased when the hybridomas are maintainedat a relatively high cell density. Neuriminidase and pronasedeplete the epitope recognized by mAb 984D4.6.5. Protein synthesisand glycosylation inhibitors also reduce expression of thisepitope. These observations suggest that the epitope recognizedby 984D4.6.5 is a carbohydrate linked to a polypeptide. Thisantibody was tested by ELISA for binding to a large panel ofcarbohydrates and glycollpids coupled to BSA. The only one thatbound 984D4.6.5 was LS tetrasaccharide c (NeuNAc2-6Galpß1-4GIcNAcß1-3GaIß1-4Glc),an O-linked carbohydrate. Comparative analysis shows that boththe sequence and the linkage of these sugars are essential tothe reactivity with the 984D4.6.5 antibody. This epitope isexpressed by a glycoprotein of-200 kDa, as shown by Westernblots. The identity of this glycoprotein remains to be determined,but indirect evidence suggests that it is not CD45. 相似文献
58.
59.
Pierce C 《Health data management》1995,3(10):70-2, 74
60.
Pierce C 《Health data management》1995,3(8):65-6, 69-70
A growing number of the nation's 67 Blue Cross and Blue Shield plans, many of which are dominant health insurers in their markets, are attempting to expand their electronic health care transactions business. At least a dozen plans have created claims clearinghouses designed to handle claims and other electronic transactions destined for any payer. 相似文献